Genesys International Balance Sheet Health
Financial Health criteria checks 4/6
Genesys International has a total shareholder equity of ₹5.1B and total debt of ₹596.1M, which brings its debt-to-equity ratio to 11.7%. Its total assets and total liabilities are ₹6.8B and ₹1.6B respectively. Genesys International's EBIT is ₹705.3M making its interest coverage ratio 14.8. It has cash and short-term investments of ₹169.8M.
Key information
11.7%
Debt to equity ratio
₹596.10m
Debt
| Interest coverage ratio | 14.8x |
| Cash | ₹169.75m |
| Equity | ₹5.12b |
| Total liabilities | ₹1.64b |
| Total assets | ₹6.76b |
Recent financial health updates
Genesys International (NSE:GENESYS) Takes On Some Risk With Its Use Of Debt
Aug 17
Genesys International (NSE:GENESYS) Has A Pretty Healthy Balance Sheet
Mar 30Genesys International (NSE:GENESYS) Has A Pretty Healthy Balance Sheet
Dec 26Is Genesys International (NSE:GENESYS) Using Too Much Debt?
Jan 10Recent updates
Investors Appear Satisfied With Genesys International Corporation Limited's (NSE:GENESYS) Prospects As Shares Rocket 25%
Dec 05Here's Why Genesys International (NSE:GENESYS) Has Caught The Eye Of Investors
Nov 29Returns At Genesys International (NSE:GENESYS) Are On The Way Up
Oct 23This Is The Reason Why We Think Genesys International Corporation Limited's (NSE:GENESYS) CEO Might Be Underpaid
Sep 24Market Participants Recognise Genesys International Corporation Limited's (NSE:GENESYS) Revenues Pushing Shares 25% Higher
Sep 06Genesys International Corporation Limited (NSE:GENESYS) Looks Just Right With A 38% Price Jump
Jul 12The Return Trends At Genesys International (NSE:GENESYS) Look Promising
Jun 23Genesys International's (NSE:GENESYS) Solid Earnings May Rest On Weak Foundations
Jun 07Investors Still Waiting For A Pull Back In Genesys International Corporation Limited (NSE:GENESYS)
May 28Market Participants Recognise Genesys International Corporation Limited's (NSE:GENESYS) Revenues Pushing Shares 25% Higher
Feb 03Slowing Rates Of Return At Genesys International (NSE:GENESYS) Leave Little Room For Excitement
Jan 06Why Investors Shouldn't Be Surprised By Genesys International Corporation Limited's (NSE:GENESYS) 35% Share Price Surge
Dec 18Genesys International (NSE:GENESYS) Takes On Some Risk With Its Use Of Debt
Aug 17Returns On Capital Signal Tricky Times Ahead For Genesys International (NSE:GENESYS)
May 05Genesys International (NSE:GENESYS) Has A Pretty Healthy Balance Sheet
Mar 30Genesys International (NSE:GENESYS) Has A Pretty Healthy Balance Sheet
Dec 26Investors Could Be Concerned With Genesys International's (NSE:GENESYS) Returns On Capital
May 24Is Genesys International (NSE:GENESYS) Using Too Much Debt?
Jan 10Calculating The Fair Value Of Genesys International Corporation Limited (NSE:GENESYS)
Feb 23Should You Take Comfort From Insider Transactions At Genesys International Corporation Limited (NSE:GENESYS)?
Jan 01The Non-Executive Non-Independent Director of Genesys International Corporation Limited (NSE:GENESYS), Ganapathy Vishwanathan, Just Bought 12% More Shares
Sep 18
Non-Executive Non-Independent Director Ganapathy Vishwanathan Just Bought 8.7% More Shares In Genesys International Corporation Limited (NSE:GENESYS)
Sep 04Genesys International Corporation Limited's (NSE:GENESYS) Shares May Have Run Too Fast Too Soon
Jul 26Financial Position Analysis
Short Term Liabilities: GENESYS's short term assets (₹3.4B) exceed its short term liabilities (₹1.3B).
Long Term Liabilities: GENESYS's short term assets (₹3.4B) exceed its long term liabilities (₹357.0M).
Debt to Equity History and Analysis
Debt Level: GENESYS's net debt to equity ratio (8.3%) is considered satisfactory.
Reducing Debt: GENESYS's debt to equity ratio has increased from 4.7% to 11.7% over the past 5 years.
Debt Coverage: GENESYS's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: GENESYS's interest payments on its debt are well covered by EBIT (14.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 12:51 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genesys International Corporation Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |
| Vijay Madunala | FirstCall Research |